Evidence map›Paper›PMID 40424271›Full record

ArticlePloS one2025

Cnot4 heterozygosity attenuates high fat diet-induced obesity in mice and impairs PPARγ-mediated adipocyte differentiation.

Tomokazu Yamaguchi, Midori Hoshizaki, Yumiko Imai, Tadashi Yamamoto, Keiji Kuba

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tomokazu YamaguchiDepartment of Pharmacology, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Midori HoshizakiDepartment of Pharmacology, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Yumiko ImaiDepartment of Medical Infection System, Research Institute Nozaki Tokushukai Hospital, Osaka, Japan.
Tadashi YamamotoCell Signal Unit, Okinawa Institute of Science and Technology, Okinawa, Japan.
Keiji KubaDepartment of Pharmacology, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.ORCID 0000-0002-2203-5293

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adipocyte differentiation is crucial for formation and expansion of white adipose tissue and is also associated with the pathologies of obesity. CNOT4 is an E3 ubiquitin ligase and also contains RNA binding domain. In mammals CNOT4 has been suggested to interact with CCR4-NOT complex, a major executor of mRNA poly(A) shortening. While several subunits within the CCR4-NOT complex were shown to be involved in obesity and energy metabolism, the roles of CNOT4 in obesity remain unexplored. In this study, we generated and analyzed Cnot4 knockout mice and found that Cnot4 heterozygous (Cnot4 Het) mice exhibit resistance to high fat diet-induced obesity, including significant reduction in adipose tissue mass and hepatic lipid depots. However, Cnot4 Het did not affect mRNA expression of metabolic genes as well as serum lipid levels or glucose tolerance. On the other hand, Cnot4 Het fibroblasts significantly reduced the capability of differentiation into adipocytes and down-regulated adipogenic gene expression compared to wild type fibroblasts. Mechanistically, heterozygous deletion of Cnot4 down-regulated the transcriptional activity through decreased binding of PPARγ to promoter region of the target gene, thereby suppressing up-regulation of adipocyte marker gene expression in response to rosiglitazone, a PPARγ agonist. These results suggest that CNOT4 mediates adipocyte differentiation during formation and growth of adipose tissue partly through positively regulating transcriptional activity of PPARγ.

Indexed as

AdipocytesCell DifferentiationDiet, High-FatObesityPPAR gammaAdipogenesisAnimalsHeterozygoteMaleMiceMice, Inbred C57BLMice, KnockoutPPAR gamma

Identifiers

PMID40424271
PMCPMC12111730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.